Nautilus Biotechnolgy, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Nautilus Biotechnolgy, Inc. (NAUT) is 146.81M

According to Nautilus Biotechnolgy, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 146.81M. This represents a change of -48.09% compared to the average of 282.80M of the last 4 quarters.

Nautilus Biotechnolgy, Inc. (NAUT) Historical Enterprise Value (quarterly & annually)

How has NAUT Enterprise Value performed in the past?

The mean historical Enterprise Value of Nautilus Biotechnolgy, Inc. over the last ten years is 253.96M. The current 146.81M Enterprise Value has changed 5.68% with respect to the historical average. Over the past ten years (40 quarters), NAUT's Enterprise Value was at its highest in in the September 2020 quarter at 1.34B. The Enterprise Value was at its lowest in in the March 2020 quarter at 76.13M.

Nautilus Biotechnolgy, Inc. (NAUT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nautilus Biotechnolgy, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nautilus Biotechnolgy, Inc. (NAUT) Average Enterprise Value

How has NAUT Enterprise Value performed in the past?

The current Enterprise Value of Nautilus Biotechnolgy, Inc. (NAUT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nautilus Biotechnolgy, Inc. (NAUT) Enterprise Value vs. Peers

How is NAUT’s Enterprise Value compared to its peers?

Nautilus Biotechnolgy, Inc.’s Enterprise Value is less than Foghorn Therapeutics Inc. (231.38M), less than Immuneering Corporation (3.83B), less than Enanta Pharmaceuticals, Inc. (513.72M), less than Pyxis Oncology, Inc. (196.02M), greater than Tenaya Therapeutics, Inc. (88.75M), less than Zura Bio Limited (278.84M), less than Assembly Biosciences, Inc. (370.44M), greater than Humacyte, Inc. (122.29M), less than Sagimet Biosciences Inc. (192.79M), greater than Arcturus Therapeutics Holdings Inc. (-22818430.00),

Build a custom stock screener for Nautilus Biotechnolgy, Inc. (NAUT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nautilus Biotechnolgy, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nautilus Biotechnolgy, Inc. (NAUT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nautilus Biotechnolgy, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.